All data are based on the daily closing price as of June 6, 2025
b

Boryung

003850.KO
6.36 USD
0.03
+0.47%

Overview

Last close
6.36 usd
Market cap
534.26M usd
52 week high
10.04 usd
52 week low
5.24 usd
Target price
11.04 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7092
Price/Book Value
0.9363
Enterprise Value
624.53M usd
EV/Revenue
0.8289
EV/EBITDA
9.0186

Key financials

Revenue TTM
753.44M usd
Gross Profit TTM
265.74M usd
EBITDA TTM
79.19M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
763.12M usd
Net debt
N/A usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top